Adenocarcinoma of the Pancreas

Oncology
1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Debiopharm
DebiopharmSwitzerland - Lausanne
1 program
1
PembrolizumabPhase 1Monoclonal Antibody
Ipsen
IpsenChina - Tianjin
1 program
Surgical resectionN/A1 trial
Active Trials
NCT07340151Not Yet Recruiting40Est. Dec 2028

Trial Timeline

Clinical trial activity over time

2026
2027
2028
IpsenSurgical resection

Clinical Trials (1)

Total enrollment: 40 patients across 1 trials

NCT07340151IpsenSurgical resection

Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma

Start: Feb 2026Est. completion: Dec 202840 patients
N/ANot Yet Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
13m ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
14m ago

Office Administrator

SystImmune
14m ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
24m ago

Working Student Office Management Support (m/f/d)

Mindpeak
Hamburg
28m ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
28m ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)